BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25341889)

  • 21. Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.
    Manderstedt E; Lind-Halldén C; Halldén C; Elf J; Svensson PJ; Dahlbäck B; Engström G; Melander O; Baras A; Lotta LA; Zöller B;
    J Am Heart Assoc; 2022 Feb; 11(4):e023018. PubMed ID: 35112923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.
    Bucciarelli P; De Stefano V; Passamonti SM; Tormene D; Legnani C; Rossi E; Castaman G; Simioni P; Cini M; Martinelli I
    Blood; 2013 Oct; 122(15):2555-61. PubMed ID: 23913469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case-control study.
    Delluc A; Gourhant L; Lacut K; Mercier B; Audrezet MP; Nowak E; Oger E; Leroyer C; Mottier D; Le Gal G; Couturaud F
    Thromb Haemost; 2010 Jun; 103(6):1161-9. PubMed ID: 20352152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
    Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
    Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
    Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.
    Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
    Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. F11 is associated with recurrent VTE in women. A prospective cohort study.
    Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
    Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that predict risk of thrombosis in relatives of patients with unprovoked venous thromboembolism.
    Couturaud F; Leroyer C; Julian JA; Kahn SR; Ginsberg JS; Wells PS; Douketis JD; Mottier D; Kearon C
    Chest; 2009 Dec; 136(6):1537-1545. PubMed ID: 19592474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study.
    Limperger V; Kenet G; Kiesau B; Köther M; Schmeiser M; Langer F; Juhl D; Shneyder M; Franke A; Klostermeier UK; Mesters R; Rühle F; Stoll M; Steppat D; Kowalski D; Rocke A; Kuta P; Bajorat T; Torge A; Neuner B; Junker R; Nowak-Göttl U
    J Thromb Thrombolysis; 2021 Feb; 51(2):494-501. PubMed ID: 32594420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of genetic testing in adults with a history of venous thromboembolism.
    Segal JB; Brotman DJ; Emadi A; Necochea AJ; Samal L; Wilson LM; Crim MT; Bass EB
    Evid Rep Technol Assess (Full Rep); 2009 Jun; (180):1-162. PubMed ID: 20629476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic screening for the predisposition to venous thromboembolism: a cost-utility analysis of clinical practice in the Italian health care system.
    Compagni A; Melegaro A; Tarricone R
    Value Health; 2013; 16(6):909-21. PubMed ID: 24041341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
    Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
    Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.